Particle.news

India Dedicates First Indigenous H5N1 Vaccine for Chickens

The inactivated vaccine targets the Clade 2.3.2.1a strain and could cut poultry deaths and human exposure if scaled production, rollout and farm biosecurity follow.

Overview

  • ICAR‑NIHSAD’s inactivated H5N1 vaccine was dedicated to the nation on Friday as a strain‑matched tool for chickens against Clade 2.3.2.1a infections.
  • Media reports of ICAR‑NIHSAD trials say a single dose showed encouraging safety and efficacy in layer and breeder birds and may protect for up to six months.
  • Officials have not disclosed commercial availability, manufacturing scale, pricing or a national vaccination schedule, leaving wide questions about how quickly the vaccine can reach farms.
  • Recent state outbreaks, including heavy losses and culling in Tamil Nadu and Andhra Pradesh, underline that vaccination must be paired with rapid testing, surveillance and strict farm biosecurity to control spread.
  • India has recorded more than 500 H5N1/H5N8 outbreaks since 2006, and global WHO data show H5N1 has caused human infections and deaths, so experts say the vaccine could reduce exposure risk but will not by itself eliminate the threat.